Back
Dorman Products Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
40
DORM
Dorman Products
Last Price:
$123.26
Seasonality Move:
3.02%
Buy
53
ALNY
Alnylam Pharmaceuticals
Last Price:
$309.80
Seasonality Move:
23.54%
Sell
40
Dorman Products (DORM)
is a Sell
Is Dorman Products a Buy, Sell or Hold?
-
The current Dorman Products [DORM] share price is $123.23. The Score for DORM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
DORM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $309.70. The Score for ALNY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DORM Stock Price Chart
What is Dorman Products's stock price today?
-
The Dorman Products share price today is $123.23The current trend is moderately bearish and DORM is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $309.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
DORM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.7 | Buy |
Relative Strength Index (14 RSI): | 45.07 | Sell |
Chaikin Money Flow: | 151432 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (124.43 - 129.53) | Sell |
Bollinger Bands (100): | (117.65 - 130.69) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.08 | Buy |
Relative Strength Index (14 RSI): | 63.6 | Buy |
Chaikin Money Flow: | -906896 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (290.37 - 307.87) | Buy |
Bollinger Bands (100): | (243.45 - 290.53) | Buy |
DORM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 124.87 | Sell |
20-day SMA: | 126.23 | Sell |
50-day SMA: | 121.85 | Buy |
200-day SMA: | 124.38 | Sell |
8-day EMA: | 124.21 | Sell |
20-day EMA: | 125.05 | Sell |
50-day EMA: | 114.44 | Buy |
200-day EMA: | 57.85 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 306.65 | Buy |
20-day SMA: | 301.66 | Buy |
50-day SMA: | 275.02 | Buy |
200-day SMA: | 264.21 | Buy |
8-day EMA: | 307.54 | Buy |
20-day EMA: | 300.26 | Buy |
50-day EMA: | 284.21 | Buy |
200-day EMA: | 258.21 | Buy |
Dorman Products Earnings Growth & DORM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.02 per share, an increase this year of $0.91 per share, and an increase next year of $0.67 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.04 per share, an increase next quarter of $1.63 per share, an increase this year of $1.19 per share, and an increase next year of $3.19 per share.
Dorman Products Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |